Literature DB >> 12845579

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma.

L Z Wang1, B C Goh, M E Grigg, S C Lee, Y M Khoo, H S Lee.   

Abstract

A novel, rapid and sensitive isocratic liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for quantification of docetaxel in human plasma with paclitaxel as internal standard. The high sensitivity and specificity of MS/MS detection enabled the use of a small volume of plasma (0.05 mL) and a simple liquid-liquid extraction procedure. Furthermore, a very short run-time (3 min) fulfilled the need for monitoring plasma levels of docetaxel from large-scale clinical studies. The calibration curve for docetaxel was linear over the range 5-1000 ng/mL with coefficients of correlation >0.999 using only 0.05 mL plasma. The intra- and inter-day precisions (CV) of analysis were <7%, and accuracy ranged from 96 to 110%. The applicability of the method was demonstrated in a pharmacokinetic study of a 1-h infusion of docetaxel with dosages of 75 mg/m(2). Possible conjugated metabolites of docetaxel were not detected in patients' samples. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845579     DOI: 10.1002/rcm.1091

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  9 in total

1.  Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity.

Authors:  Mingming Zhao; Min Su; Xia Lin; Yanfei Luo; Haibing He; Cuifang Cai; Xing Tang
Journal:  Pharm Res       Date:  2010-06-15       Impact factor: 4.200

2.  Quantitative analysis of 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane, a potent synthetic steroidal liver X receptor agonist in plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Jian Guo; Dacheng Peng; Qing Dai; Shutsung Liao; Brian J Wright; Richard B van Breemen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

Review 3.  Clinical pharmacokinetics of docetaxel : recent developments.

Authors:  Sharyn D Baker; Alex Sparreboom; Jaap Verweij
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.

Authors:  Gary Hudes; Scott T Tagawa; Young E Whang; Ming Qi; Xiang Qin; Thomas A Puchalski; Manjula Reddy; Mark Cornfeld; Mario Eisenberger
Journal:  Invest New Drugs       Date:  2012-07-25       Impact factor: 3.850

5.  Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry.

Authors:  Julio R Gaspar; Jun Qu; Ninfa L Straubinger; Robert M Straubinger
Journal:  Analyst       Date:  2008-10-03       Impact factor: 4.616

6.  Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry.

Authors:  Haoying Yu; Robert M Straubinger; Jin Cao; Hao Wang; Jun Qu
Journal:  J Chromatogr A       Date:  2008-09-19       Impact factor: 4.759

7.  High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.

Authors:  Anders Andersen; David J Warren; Paal F Brunsvig; Steinar Aamdal; Gunnar B Kristensen; Harald Olsen
Journal:  BMC Clin Pharmacol       Date:  2006-01-13

8.  ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.

Authors:  Hee-Jun Kim; Seock-Ah Im; Bhumsuk Keam; Hye Seon Ham; Kyung Hun Lee; Tae Yong Kim; Yu Jung Kim; Do-Youn Oh; Jee Hyun Kim; Wonshik Han; In-Jin Jang; Tae-You Kim; In Ae Park; Dong Young Noh
Journal:  Cancer Sci       Date:  2014-12-08       Impact factor: 6.716

9.  Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.

Authors:  Nicholas Li-Xun Syn; Lingzhi Wang; Andrea Li-Ann Wong; Mu-Yar Soe; Benjamin Chuah; Daniel Chan; Sing-Huang Tan; Ross Andrew Soo; Soo-Chin Lee; Boon-Cher Goh; Wei-Peng Yong
Journal:  Cancer Sci       Date:  2016-02-08       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.